Darrel R. Borger

571 total citations
7 papers, 374 citations indexed

About

Darrel R. Borger is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Darrel R. Borger has authored 7 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Surgery and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Darrel R. Borger's work include Cancer Genomics and Diagnostics (2 papers), Pancreatic and Hepatic Oncology Research (1 paper) and Sarcoma Diagnosis and Treatment (1 paper). Darrel R. Borger is often cited by papers focused on Cancer Genomics and Diagnostics (2 papers), Pancreatic and Hepatic Oncology Research (1 paper) and Sarcoma Diagnosis and Treatment (1 paper). Darrel R. Borger collaborates with scholars based in United States. Darrel R. Borger's co-authors include Paul E. Goss, Judy E. Garber, Erica L. Mayer, Steven J. Isakoff, Eric P. Winer, Lisa A. Carey, Vered Stearns, Leif W. Ellisen, Steven E. Come and Paula D. Ryan and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and The American Journal of Surgical Pathology.

In The Last Decade

Darrel R. Borger

6 papers receiving 367 citations

Peers

Countries citing papers authored by Darrel R. Borger

Since Specialization

Citations

This map shows the geographic impact of Darrel R. Borger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darrel R. Borger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darrel R. Borger more than expected).

Fields of papers citing papers by Darrel R. Borger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darrel R. Borger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darrel R. Borger. The network helps show where Darrel R. Borger may publish in the future.

Co-authorship network of co-authors of Darrel R. Borger

This figure shows the co-authorship network connecting the top 25 collaborators of Darrel R. Borger. A scholar is included among the top collaborators of Darrel R. Borger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darrel R. Borger. Darrel R. Borger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	Evolutionary Analysis of Pre- and Post-treatment Molecular Diversity in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiation (CRT) and a KRAS Mutation-targeted Radiosensitizer 2020 ·International Journal of Radiation OncologyBiologyPhysics ·Sophia C. Kamran, Christine E. Eyler, Jochen K. Lennerz, Jennifer Y. Wo, (unknown), Hui Zheng, Darrel R. Borger, Jill N. Allen, David L. Berger, James C. Cusack, (unknown), Andrew X. Zhu, Jeffrey W. Clark, Jason A. Efstathiou, Henning Willers, (unknown), Kevin M. Haigis, Theodore S. Hong	0
2	Mutational Landscape and Genetic Determinants of Response to Trimodality Therapy in Muscle-Invasive Bladder Cancer 2020 ·International Journal of Radiation OncologyBiologyPhysics ·David T. Miyamoto, Sophia C. Kamran, Kent W. Mouw, (unknown), Shu‐Ju Wu, (unknown), (unknown), Koji Otani, Darrel R. Borger, Jochen K. Lennerz, (unknown), Henning Willers, Tingting Hong, William U. Shipley, Jason A. Efstathiou	2
3	Checkpoint inhibitor signatures across endometrial carcinoma histologic subtypes 2018 ·Gynecologic Oncology ·(unknown), (unknown), (unknown), David W. Jenkins, Darrel R. Borger, Whitfield B. Growdon	3
4	Clinical and Molecular Predictors of Local Failure After SBRT for Liver Metastases: A Secondary Analysis of a Prospective Phase II Trial 2015 ·International Journal of Radiation OncologyBiologyPhysics ·Jennifer Y. Wo, Andrew X. Zhu, Erin McDonnell, B.Y. Yeap, Darrel R. Borger, A. John Iafrate, Lorraine C. Drapek, Lawrence S. Blaszkowsky, E.L. Kwak, Jeffrey W. Clark, Lipika Goyal, Jill N. Allen, David P. Ryan, Ronald S. Arellano, John A. Wolfgang, John T. Mullen, Harvey J. Mamon, Thomas F. DeLaney, Theodore S. Hong	2
5	TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer 2015 ·Journal of Clinical Oncology ·Steven J. Isakoff, Erica L. Mayer, Lei He, Tiffany A. Traina, Lisa A. Carey, Karen J. Krag, Hope S. Rugo, Minetta C. Liu, Vered Stearns, Steven E. Come, Kirsten M. Timms, Anne-Renee Hartman, Darrel R. Borger, Dianne M. Finkelstein, Judy E. Garber, Paula D. Ryan, Eric P. Winer, Paul E. Goss, Leif W. Ellisen	292
6	Extensive Squamous Cell Carcinoma of the Skin Related to Use of Sorafenib for Treatment of FLT3-Mutant Acute Myeloid Leukemia 2014 ·Journal of Clinical Oncology ·Amir T. Fathi, William M. Lin, (unknown), Adriano Piris, Hossein Sadrzadeh, Lindsay A. Bernardo, Darrel R. Borger, Steven L. McAfee, Daniela Kroshinsky, Yi‐Bin Chen	2
7	Molecular Distinction of Chondrosarcoma From Chondroblastic Osteosarcoma Through IDH1/2 Mutations 2013 ·The American Journal of Surgical Pathology ·Darcy A. Kerr, (unknown), Vikram Deshpande, Francis J. Hornicek, Zhenfeng Duan, Yaxia Zhang, Andrew E. Rosenberg, Darrel R. Borger, G. Petur Nielsen	73

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact